Showing results (1-10 of 569) with videos related to

Sort By:
Pageof 57
Annals of Hematology|July 12, 2001
Primary lymphoma of the conjunctiva--a rare manifestation of indolent non-Hodgkin's lymphomaM Reiser, A Josting, V Diehl, et al.
Der Internist|January 22, 2004
[Modern pharmacotherapy of Hodgkin disease]A Josting, K Behringer, A Engert, et al.
Medizinische Klinik (Munich, Germany : 1983)|September 25, 1999
[Role of high-dose chemotherapy in hematology and internal medicine/ oncology]A Engert, A Josting, M Reiser, et al.
Blood|August 15, 2000
Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: a report from the German Hodgkin Lymphoma Study GroupA Josting, U Rueffer, J Franklin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2000
Treatment of primary progressive Hodgkin's and aggressive non-Hodgkin's lymphoma: is there a chance for cure?A Josting, M Reiser, U Rueffer, et al.
Cancer Journal (Sudbury, Mass.)|May 10, 2000
Hodgkin's diseaseV Diehl, A Josting
Current Oncology Reports|April 11, 2001
Early-stage Hodgkin's diseaseA Josting, V Diehl
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 20, 2010
Impact of first- and second-line treatment for Hodgkin's lymphoma on the incidence of AML/MDS and NHL--experience of the German Hodgkin's Lymphoma Study Group analyzed by a parametric model of carcinogenesisM Scholz, A Engert, J Franklin, et al.
Leukemia & Lymphoma|August 3, 2002
T-cell non-Hodgkin's lymphoma in adults: clinicopathological characteristics, response to treatment and prognostic factorsM Reiser, A Josting, M Soltani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2004
Solid tumors in patients treated for Hodgkin's disease: a report from the German Hodgkin Lymphoma Study GroupK Behringer, A Josting, P Schiller, et al.
Pageof 57